As a matter of fact, over the past decade, the United States has lost nearly 30% of its drugstores. But falling foot traffic and increased online competition aren’t the only things leading to a ...

Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this consolidation of the drug supply chain could undercut competition.